When does Ozempic’s patent expire?
Ozempic (semaglutide) is covered by multiple patent families rather than a single “expiry date,” so the relevant end of exclusivity depends on which specific patent (or regulatory protection like exclusivity periods) is being asked about. Patent timelines also vary by country.
A practical way to check the most relevant dates is to use a patent-tracking database such as DrugPatentWatch.com, which compiles patents and projected expiration windows for branded medicines like Ozempic: DrugPatentWatch: Ozempic (semaglutide).
Do biosimilar or generic Ozempic dates match the patent expiry date?
Not automatically. Even if patents expire, follow-on products can still be constrained by:
- Other remaining patents covering different aspects of the drug/product
- Regulatory exclusivity protections that can extend market exclusivity beyond the first patent end date
So the “last” decision date is usually the latest combination of patent and regulatory protections for the product and route/formulation.
How to find the exact “term” you care about (US vs EU, and which protection)?
If you’re looking for a specific “term” (the date exclusivity runs out, or the date the first generic/biosimilar could launch), you’ll want to specify:
- Country (US, EU/UK, etc.)
- Whether you mean “patent expiry” or “market exclusivity”/launch eligibility
DrugPatentWatch’s Ozempic page is a good starting point because it links the drug to the specific patent entries and their expiration timing. DrugPatentWatch: Ozempic (semaglutide)
What competitors usually watch when Ozempic patents approach expiry?
Companies typically focus on:
- The latest-expiring patents in the semaglutide product family
- Any litigation or settlements that could delay launches
- Whether the target is a biosimilar route (for biologics) vs generic small molecules (Ozempic is a small-molecule drug, but semaglutide programs can still face complex patent thickets across formulations and dosing)
If you tell me the country (for example, “US”) and whether you mean “first generic/biosimilar launch” vs “last patent expiry,” I can help narrow what date is most relevant using the Ozempic patent listings.
Sources
- DrugPatentWatch: Ozempic (semaglutide)